Cardiff Oncology Inc. (CRDF) Fundamentals

Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
SHARE INFORMATION
Market Cap$ 123,937,868
Shares Outstanding43,334,919
Float42,661,834
Percent Float98.45%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 359,000
Latest Fiscal EPS$ -0.72
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions200
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months1,442,279
Institutional Holdings Percent49.4%
Institutional Sold Previous 3 Months5,868,270
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months153,176
Insider Holdings Percent3.8
Insider Sold Previous 3 Months28,858
Insider Shares Owned1,652,940
TRADING INFO
52 Week High$ 8.58
52 Week Low$ 1.13
52 Week High Change$ -50.52
21 Day Moving Average$ 2.4148
21 Day Extended Moving Average$ 2.3994
50 Day Moving Average$ 2.1818
50 Day Extended Moving Average$ 2.2547
200 Day Moving Average$ 3.3689
200 Day Extended Moving Average$ 3.3807
10 Day Average Volume526,207
20 Day Average Volume521,730
30 Day Average Volume730,467
50 Day Average Volume1,080,545
Alpha-0.017308
Beta1.4771
Standard Deviation0.331508
R20.049667
7 Day Price Change$ 0.81
7 Day Percent Change39.51%
21 Day Price Change$ 0.51
21 Day Percent Change21.7%
30 Day Price Change$ -0.30
30 Day Percent Change-9.49%
Month to Date Price Change$ 0.65
Month to Date Percent Change29.41%
Quarter to Date Price Change$ 0.66
Quarter to Date Percent Change30.0%
180 Day Price Change$ -0.60
180 Day Percent Change-17.34%
200 Day Price Change$ -0.835
200 Day Percent Change-22.6%
Year to Date Price Change$ -3.15
Year to Date Percent Change-52.41%

Cardiff Oncology Inc. (CRDF) Key Ratios

PROFITABILITY
EBIT Margin-9,759.6%
EBITDA Margin-9,683.6%
Pre-Tax Profit Margin-5,672.7%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 384,000
Revenue Per Share$ 0.0089
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.00
Total Debt To Equity0.00
Int Coverage-17,679.10
Current Ratio15.00
Leverage Ratio1.10
Quick Ratio14.50
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-3.20
Enterprise Value$ 4,907,868
Price to Sales322.7549
Price to Free Cash-4.10
PE High Last 5 Years-0.60
Price To Book1.00
Price To Cash Flow0.00
PE Low Last 5 Years-4.10
Price to Tangible Book1.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.50
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-27.50
Return on Equity-29.16
Return on Capital-29.19

Cardiff Oncology Inc. (CRDF) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOMark Erlander
Emplyoees23
Last AuditUQ
CIK0001213037
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address11055 Flintkote Avenue
San Diego, CA 92121
Websitehttps://www.cardiffoncology.com
Facsimile+1 858 952-7571
Telephone+1 858 952-7570
Emailir@trovagene.com


Your Recent History
NASDAQ
CRDF
Cardiff On..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.